SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)
KG 23.52-4.6%Oct 29 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Randi who wrote ()8/30/1999 5:18:00 AM
From: Walkingshadow   of 61
 
Update on Altace, HOPE trial, and Barcelona:

According to KING IR, all the VIPs at KING are currently in Barcelona. The presentation of the results will occur on Tuesday the 31st. A press release will be issued. Also, the full report has been submitted to a major medical journal and, reportedly, accepted for publication late this year. I have it from sources other than KING that the gist of the report will be that the HOPE trial results indicate that Altace is a grossly underprescribed drug.

KING was up over 6% on Friday, and volume has been increasing steadily of late. This will be interesting.....

But, based on what happened in May after the preliminary results were released and the stock then proceeded to decline, I will probably place stop limits on Monday or Tuesday, depending on what happens to the stock price. Might have to make a quick exit on this one.....

Regards,

Walkingshadow
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext